hepatitis B News
Most Popular hepatitis B Story
Dynavax shares soar as FDA clears hep B trial
Over at FierceVaccines this morning, we take a look at several key biotech developments. Dynavax Technologies' shares soared 75 percent after the FDA lifted its clinical hold on the developer's Read more...
Latest Headlines
- May 4, 2010
- September 9, 2009
- August 6, 2008
- May 16, 2008
- April 17, 2008
- March 18, 2008
- October 3, 2007
- September 28, 2007
- September 21, 2007
- September 11, 2007
- August 2, 2007
- July 17, 2007
- July 13, 2007
- February 1, 2007
- December 13, 2006
- December 12, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
